gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Neuroendocrine Tumors in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hicks, RM; Hope, TA; Loening, AM; Ohliger, MA; Vasanawala, SS | 1 |
| Auernhammer, CJ; Bartenstein, P; Cyran, CC; Geisler, J; Haug, AR; Ilhan, H; Koch, W; Spitzweg, C | 1 |
| Baum, RP; Bonomo, L; Carreras, C; Castaldi, P; De Gaetano, AM; Giordano, A; Hommann, M; Hörsch, D; Kaemmerer, D; Rufini, V; Treglia, G | 1 |
| Gueye, C; Laissy, JP; Scherrer, A; Somveille, E; Soyer, P | 1 |
| Laissy, JP; Menu, Y; Sibert, A; Soyer, P; Tidjani, K | 1 |
1 review(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Neuroendocrine Tumors
| Article | Year |
|---|---|
Role of PET/CT in the functional imaging of endocrine pancreatic tumors.
Topics: Cell Differentiation; Contrast Media; Dopamine Agents; Heterocyclic Compounds; Humans; Levodopa; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Peptide Hormones; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
4 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Neuroendocrine Tumors
| Article | Year |
|---|---|
Variable refocusing flip angle single-shot fast spin echo imaging of liver lesions: increased speed and lesion contrast.
Topics: Adult; Aged; Echo-Planar Imaging; Female; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals | 2018 |
Treatment with octreotide in patients with well-differentiated neuroendocrine tumors of the ileum: prognostic stratification with Ga-68-DOTA-TATE positron emission tomography.
Topics: Adult; Aged; Aged, 80 and over; Female; Heterocyclic Compounds; Humans; Ileal Neoplasms; Male; Middle Aged; Neuroendocrine Tumors; Octreotide; Organometallic Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Survival Analysis; Treatment Outcome | 2014 |
MR diagnosis of hepatic metastases from neuroendocrine tumors versus hemangiomas: relative merits of dynamic gadolinium chelate-enhanced gradient-recalled echo and unenhanced spin-echo images.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Chelating Agents; Contrast Media; Diagnosis, Differential; Female; Gadolinium; Hemangioma, Cavernous; Heterocyclic Compounds; Humans; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Observer Variation; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity; Statistics, Nonparametric | 1995 |
Dynamic Gd-DOTA-enhanced MR imaging of hepatic metastases from pancreatic neuroendocrine tumors.
Topics: Adult; Aged; Carcinoid Tumor; Chelating Agents; Contrast Media; Female; Gadolinium; Gastrinoma; Heterocyclic Compounds; Humans; Image Enhancement; Insulinoma; Liver Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neuroendocrine Tumors; Organometallic Compounds; Pancreatic Neoplasms; Prospective Studies; Retrospective Studies; Vipoma | 1994 |